Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpha Corporation is a Japanese ophthalmic medical device company focused on orthokeratology lenses for myopia correction and myopia-management related vision care. The company developed and commercializes ALPHA ORTHO-K, and it states that it was the first company in Japan to obtain marketing approval for orthokeratology lenses. Alpha has manufacturing roots in rigid gas permeable contact lenses and has expanded its orthokeratology business across Japan and multiple Asian markets including China, South Korea, Singapore, Malaysia, Australia, Indonesia, India, and Vietnam. In 2016, Alpha became part of the Menicon Group, and it now operates as a Menicon subsidiary. Its business is centered on commercial-stage specialty contact lenses rather than a traditional drug-development biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpha Corporation.